SS Innovations International Inc. (Nasdaq: SSII), a pioneering surgical robotics company, rang the opening bell at the Nasdaq MarketSite in New York, marking its official entry into the global capital markets. This milestone signifies not only the company’s strategic growth but also India’s rising prominence in delivering affordable, world-class medical technologies on a global stage.

Led by Dr. Sudhir Srivastava, Founder, Chairman, and CEO, the bell-ringing ceremony was attended by SS Innovations’ leadership team, board members, and key collaborators. The celebration reflects the company’s remarkable journey, from conceptualising and building India’s first indigenously developed surgical robotic system to now being listed on one of the world’s most prestigious stock exchanges.

SSI Mantra: A Made-in-India, for-the-world solution

At the heart of this success lies the SSI Mantra Surgical Robotic System, a modular, multi-arm robotic platform tailored for a wide range of procedures including robotic cardiac, general, thoracic, gynecologic, and urologic surgeries. Designed and manufactured in India, the system offers an economical yet advanced solution to democratize access to robotic surgery globally.

With installations in over 80 hospitals across 75 Indian cities, and international reach into Nepal, Ecuador, the Philippines, Guatemala, Indonesia, Colombia, and Ukraine, the SSI Mantra is setting new standards in global health access. To date, the system has been used to complete over 4,000 surgeries spanning more than 100 procedures, all without a single complication, injury, or mortality reported—a strong validation of both safety and performance.

Financial performance reflects operational excellence

In 2024, SS Innovations reported revenues of $20.6 million, up from $5.9 million in 2023, representing a 3.5x year-over-year growth. Notably, the company’s gross margins rose to 40.9%, compared to 12.3% the previous year, pointing to increased operational efficiency and market acceptance.

Building a global footprint in robotic surgery

The company is actively expanding regulatory pathways to enter Europe and the United States, with CE Mark and FDA approvals expected in the second half of 2025. With the increasing global demand for cost-effective surgical solutions, SS Innovations is well-positioned to offer scalable technologies that can be rapidly adopted by hospitals in both developed and emerging markets.

“The bell-ringing at Nasdaq is not just a ceremonial milestone, but a reaffirmation of our vision to lead a global revolution in surgical care,” said Dr. Srivastava. “Our mission is to bring the benefits of robotic surgery to patients worldwide—without the prohibitive costs typically associated with this technology.”

Designed for Surgeons, Built for Outcomes

The SSI Mantra system features a surgeon-friendly ergonomic interface, modular robotic arms to ensure flexibility and precision, and a 3D 4K visual system that enhances intraoperative clarity for the surgical team. With over 40 robotic instruments compatible with the system and a shorter learning curve, the platform is tailored for scalability and skill transfer, especially in resource-constrained environments.

Implications for India’s healthcare innovation ecosystem

SS Innovations’ Nasdaq debut not only validates its business model but also symbolises a larger transformation in India’s medtech ecosystem. The country is increasingly being recognised as a hub for frugal, scalable, and technologically advanced healthcare solutions that can solve global challenges in surgical access and affordability.

As India continues to accelerate investments in digital health, regulatory innovation, and indigenous medical technology development, companies like SS Innovations are setting the blueprint for global competitiveness.

The success of SS Innovations is a testament to how India can leapfrog into global leadership by integrating clinical excellence, engineering innovation, and patient-centric design. As the healthcare world watches this trajectory, SS Innovations’ Nasdaq listing serves as a beacon of what is possible when ambition meets execution in India’s medtech sector.

Photo Credits: Nasdaq, Inc: Vanja Savic

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!